SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

September 30, 2010 09:05 ET

BIOLASE Announces 30 Percent Increase in Sales Force

Increase in Sales Force Positions BIOLASE for Strong Fourth Quarter

IRVINE, CA--(Marketwire - September 30, 2010) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, is pleased to announce the first phase of its planned sales force expansion in North America. 

Federico Pignatelli, Chairman and CEO, commented, "We are extremely pleased that we have achieved a 30 percent increase in our North American sales force as it will position us for stronger performance in the fourth quarter and beyond. This expansion takes us from our current sales force total of 20 to 26 with a goal of becoming 35 strong during the first quarter of 2011."

Pignatelli continued, "In addition to the expansion in our sales force, we have reorganized our service department and trained our 17 Field Service Engineers to sell laser accessories and promote upgrades from 1st and 2nd generation Waterlase® units to the new Waterlase MD Turbo™."

Pignatelli concluded, "All of these changes, coupled with the recent increases in the Section 179 tax code and the historical propensity of dentists to purchase large ticket capital equipment in the fourth quarter, bodes well for the future growth of BIOLASE."

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at, Twitter at, and YouTube at

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:
    Jill Bertotti (investors)
    Len Hall (media)
    Allen & Caron